Delivery Order SPE2DB24D2217-SPE2DB24FJVQL

Award Date 8/19/24
Potential Completion Date 9/10/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $13,846.97, is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The IDC allows...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The $12,960.30 firm-fixed-price contract is for the supply of the pharmaceutical product VYNDAMAX 61 MG CAPSULE UD 30S. The contract has an ultimate completion date of September 3, 2024 and was awarded on August 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,960.30 firm fixed-price contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, and does not have a set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for $69,234.85 and covers the supply of the medication VYNDAMAX 61 MG CAPSULE UD 30S. The contract is a firm fixed-price agreement, has an ultimate completion date of July 25, 2025, and is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a ceiling value of $83,081.82 and a period of performance through May 6, 2025. The contract is a firm fixed-price, non-set-aside arrangement, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,846.97 firm-fixed-price contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a prescription medication. The contract has an ultimate completion date of June 2, 2025. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA to provide a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a prescription medication. The ceiling value of the delivery order is $12,960.30, and it has a firm fixed price pricing type. The period of performance runs from the award date of September 10, 2024, through October 1, 2024. This delivery order is part of a larger...
This is a $27,693.94 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a period of performance through June 12, 2025. The contract is a firm-fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,846.97, is for the delivery of 30-count packages of the medication VYNDAMAX 61 MG CAPSULE UD. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,408.24, is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance through February 14, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a significant...
  • SPE2DB24D2217
    Indefinite Delivery Contract
  • SPE2DB24D2217-SPE2DB24FJVQL
    Delivery Order

This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $12,602.01 firm fixed-price contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty pharmaceutical product. This delivery order is part of AmerisourceBergen's IDC with DLA Troop Support Medical, valued at up to $999,999,999, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has an ultimate completion date of September 10, 2024 and does not use a set-aside designation.

Generated 11/18/24, 9:20 AM